The hierarchy of resistance to suppression described in this AIG model has implications for the design
of Treg-based therapies in terms of which responses can be targeted effectively by Tregs, and which type of Tregs are most appropriate for the job. This was highlighted by a further study in this experimental system, which illustrated once again the additive effects of activation status and antigen specificity in determining the capacity of Tregs to modulate autoaggressive responses. Only antigen-specific (not polyclonal) iTreg can suppress the development of Th17-induced pathology in the gastritis model . A similar pattern of responsiveness to Treg-induced suppression selleck chemicals has been observed in several other model systems. The ameliorative effect of all trans-retinoic acid treatment on the development of type 1 diabetes is dependent upon an expansion of FoxP3+
Tregs which suppress the generation of IFN-γ but not IL-17 responses . We have found that Tregs isolated from the central nervous system (CNS) of mice with EAE suppress IFN-γ production efficiently by CNS-derived effector T cells in co-culture, but are unable to suppress their production of IL-17 . Our own unpublished studies also suggest that polarized myelin-responsive Th17 populations are relatively resistant to Treg-mediated suppression of their proliferation in vitro, compared to their Th1 counterparts. GSK126 purchase Consistent data from human studies show that Th17 cells are resistant to Treg-mediated suppression at the level of proliferation , as well as cytokine production . Extrapolation of these in vitro studies would suggest that Th17
cells might preferentially resist Treg-mediated control of their clonal expansion in vivo. As yet, this has not been Dimethyl sulfoxide tested formally. It therefore appears that Th1 responses are perhaps the most acutely sensitive to Treg-mediated suppression, while Th17 responses appear most resistant. The basis for differential sensitivity to regulation remains unclear. However, factors associated with Th17 responses (IL-6, IL-21, TNF-α and potentially IL-17 itself) impair the suppressive capacity of Tregs and may thus prevent suppression of Th17 responses selectively. Several studies have presented persuasive arguments that the suppressive function of Tregs must, at times, be subverted to allow inflammatory immune responses to effectively eliminate pathogens. Central to this hypothesis is the ability of the innate immune system to sense the presence of a pathogen via Toll-like receptor (TLR) signalling and respond by producing proinflammatory cytokines such as IL-6, which overcome Treg-mediated suppression . IL-6 blockade has been shown to restrain the development of both Th1 and Th17 responses following immunization . IL-6 influences the development and expansion of effector and Treg cell responses as well as Treg function, and this has been demonstrated most elegantly in the EAE model.